Crossmark

Effectiveness and Safety of Liposomal Ferric Pyrophosphate vs. Ferrous Sulfate for Intermittent Iron Prophylaxis in Children Aged 6–59 months: A Randomized Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s12098-025-05436-7

Published Online: 2025-01-24

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Aayush

Bellad, Roopa M. https://orcid.org/0000-0003-4383-1704
Charantimath, Umesh S. https://orcid.org/0000-0003-1726-2798
License Information

Text and Data Mining valid from 2025-01-24

Version of Record valid from 2025-01-24
More Information

Article History

Received: 11 November 2024

Accepted: 14 January 2025

First Online: 24 January 2025

Declarations

:

: None.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below